(Q44540876)

4 December 2017

title

No dose-dependent tubulotoxicity of 5-aminosalicylic acid: a prospective study in patients with inflammatory bowel diseases (English)

1 reference

4 December 2017

Carsten Dehmer

1

1 reference

4 December 2017

Roland Greinwald

2

1 reference

4 December 2017

Juergen Löffler

3

1 reference

4 December 2017

Wolfgang Grotz

4

1 reference

4 December 2017

Lothar Wolf

5

1 reference

4 December 2017

Hans-Burkhardt Hagmann

6

1 reference

4 December 2017

Werner Schneider

7

1 reference

4 December 2017

Wolfgang Kreisel

8

1 reference

4 December 2017

German Salofalk Study Group

9

1 reference

4 December 2017

language of work or name

1 reference

8 February 2003

1 reference

International Journal of Colorectal Disease

4 December 2017

published in

1 reference

4 December 2017

volume

18

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

406-412

1 reference

Sulphasalazine induced renal failure

4 December 2017

cites work

1 reference

12 December 2020

Tests of renal function in patients with quiescent colitis: effects of drug treatment

1 reference

12 December 2020

Medical therapy of inflammatory bowel disease

1 reference

12 December 2020

[Chronic interstitial nephritis after treatment with 5-aminosalicylic acid]

1 reference

12 December 2020

Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease

1 reference

12 December 2020

Mesalazine: a global safety evaluation.

1 reference

12 December 2020

[Suspicion of syphilis from cross reactions in Borrelia infection]

1 reference

12 December 2020

What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?

1 reference

12 December 2020

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

1 reference

12 December 2020

Tumour necrosis factor and inflammatory bowel disease

1 reference

12 December 2020

Immunological and ultrastructural analysis of loss of tubular membrane-bound enzymes in patients with renal damage

1 reference

12 December 2020

The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity

1 reference

12 December 2020

Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use.

1 reference

12 December 2020

Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.

1 reference

12 December 2020

Soluble tumour necrosis factor receptors p55 and p75 in the urine monitor disease activity and the efficacy of treatment of inflammatory bowel disease

1 reference

12 December 2020

Alpha 1-microglobulin (protein HC): features of a promising indicator of proximal tubular dysfunction

1 reference

12 December 2020

Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis

1 reference

12 December 2020

Nephrotic syndrome after treatment with 5-aminosalicylic acid

1 reference

12 December 2020

Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease

1 reference

12 December 2020

Urinary enzymes and low molecular weight proteins as markers of tubular dysfunction.

1 reference

12 December 2020

Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn's disease

1 reference

12 December 2020

Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease

1 reference

12 December 2020

Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group

1 reference

12 December 2020

Renal function was not impaired by treatment with 5-aminosalicylic acid in rats and man

1 reference

12 December 2020

Nephrotic syndrome from 5-ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis

1 reference

12 December 2020

Interstitial nephritis in patients with inflammatory bowel disease treated with mesalamine

1 reference

12 December 2020

Nephrotic syndrome associated with sulphasalazine

1 reference

12 December 2020

Interstitial nephritis associated with 5-aminosalicylic acid

1 reference

12 December 2020

Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis

1 reference

12 December 2020

Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease.

1 reference

12 December 2020

Mesalazine induced interstitial nephritis

1 reference

12 December 2020

Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate

1 reference

12 December 2020

Management of Crohn's disease in adults

1 reference

12 December 2020

Reference range of some enzymes and proteins in untimed overnight urine and their stability after freezing

1 reference

12 December 2020

Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France

1 reference

12 December 2020

Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy

1 reference

12 December 2020

10.1007/S00384-002-0467-7

Identifiers

DOI

1 reference

release_ieobwi247vf6llutmshixuwgea

4 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ieobwi247vf6llutmshixuwgea

24 November 2022

mapped directly with Wikidata item

1 reference